Financial Performance Highlights

• Revenue Decline: Epiworld’s revenue for 2025 dropped to RMB765.3 million, down from RMB974.3 million in 2024 and RMB1,142.5 million in 2023, marking a significant slowdown in business growth.
• Profitability Impact: Gross profit also fell sharply to RMB189.9 million (vs. RMB332.3 million in 2024), and profit attributable to owners was RMB11.9 million, a dramatic fall from RMB165.1 million in 2024.
• Adjusted Net Profit: The adjusted net profit (non-IFRS measure) was RMB198.4 million in 2025, down from RMB323.5 million in 2024, reflecting a challenging operating environment, despite adjustments for share-based payments, interest on redemption rights, and listing expenses.
• Earnings Per Share: Non-IFRS earnings per share fell to RMB0.49 in 2025 from RMB0.84 in 2024, highlighting a notable decline in shareholder returns.

Balance Sheet and Liquidity

• Asset Growth: Total assets remained stable at RMB4,523.9 million (vs. RMB4,502.9 million in 2024), with current assets rising slightly to RMB2,542.7 million.
• Liabilities and Gearing: Total liabilities decreased to RMB1,514.2 million, lowering the gearing ratio to 40% from 51% in 2024, due to reduced borrowings and higher equity.
• Equity Strength: Total equity increased to RMB3,009.7 million, suggesting a stronger capital base despite profitability challenges.
• Pledged Assets: Pledged assets decreased to RMB519.5 million, indicating less reliance on secured financing.

Operational and Strategic Developments

• Product and Supply Chain Optimization:
  • Focused on optimizing raw material costs, enhancing cooperation with suppliers, and improving production yields to reduce per-wafer raw material expenditure.
  • Adopted order-based production and inventory optimization to minimize overstock and improve supply chain flexibility.
• Market Expansion:
  • Implemented targeted programs to broaden the customer base both domestically and internationally, emphasizing strategic partnerships and innovation in downstream applications.
  • Actively exploring new applications for silicon carbide devices in high-growth sectors such as AI computing, data centers, smart grids, energy storage, and eVTOL aircraft.
• Listing Milestone: On March 30, 2026, Epiworld listed its H shares on the Hong Kong Stock Exchange, raising gross proceeds of approximately HK\$1,640.0 million. This is a major event that could significantly impact share liquidity, valuation, and investor perception.

Cost Structure and Expenses

• Other Income: Slight decrease to RMB166.0 million, mainly due to higher net foreign exchange losses from US dollar depreciation, offset partially by higher bank interest income.
• Selling & Distribution Expenses: Nearly doubled to RMB10.8 million, reflecting aggressive marketing and higher sample costs.
• Administrative Expenses: Rose 18.5% to RMB208.1 million, driven by listing-related costs.
• R&D Spend: Decreased to RMB74.9 million, mainly due to falling material prices, but still substantial, showing commitment to technological innovation.
• Impairment Losses: Increased to RMB2.7 million, tied to higher trade and bills receivables.
• Finance Costs: Decreased to RMB24.9 million as borrowings fell.

Capital Expenditure, Investments, and Commitments

• Capital Expenditure: RMB146.1 million in 2025, mainly for production and R&D base construction, down from RMB206.6 million in 2024.
• Significant Investments: No material investments, acquisitions, or disposals in 2025.
• Future Plans: No new material investment plans beyond those disclosed in the IPO prospectus. This may indicate a cautious approach given the weaker profit outlook.
• Contingent Liabilities: No material contingent liabilities reported.

Risk Management and Key Uncertainties

• Financial Risks: The company actively manages interest rate, foreign exchange, credit, and liquidity risks, with hedging (USD20 million FX contracts) in place for currency risk.
• Macroeconomic and Geopolitical Risks: Exposure to global economic conditions, trade policies, and sanctions could materially affect operations and share price.
• Supply Chain and Raw Material Risks: Fluctuations or shortages may increase costs, delay deliveries, and impact market pricing.
• Innovation and Technology Risks: Failure to innovate or upgrade could result in lost market share and diminished returns.
• Quality and Reputation Risks: Product issues could damage reputation, reduce adoption, or increase liability.

Corporate Governance and Shareholder Matters

• Dividend Policy: No dividend recommended for 2025; distributable reserves stand at RMB205.0 million. The Board emphasizes sustainable development and maintaining investor returns but has discretion over future dividends.
• Share Capital: Details of share movements provided; no treasury shares held or repurchased during 2025.
• Employee and Remuneration: Workforce reduced to 529 employees (from 592 in 2024); total staff costs include competitive incentives and share-based payments.
• Social Responsibility: RMB250,000 donated to charity; ESG report released separately.
• Compliance: No material litigation or regulatory penalties reported; full compliance with laws and regulations.

Corporate Actions and Post-Reporting Events

• IPO and Capital Raise: The listing of H Shares and the resulting capital infusion is the most price-sensitive event. It provides liquidity, enhances visibility, and may drive valuation higher, but also brings increased scrutiny and reporting obligations.
• No Significant Subsequent Events: Other than the IPO, no material events occurred post reporting period.

Potential Share Price Movers

• Sharp Drop in Profitability: The drastic reduction in net profit and earnings per share will be a concern for investors and may weigh on the share price unless offset by future growth prospects or successful deployment of IPO funds.
• Successful Listing and Capital Raise: The HK\$1.64 billion raised through the IPO could be deployed for strategic expansion, R&D, or strengthening the balance sheet, potentially supporting share price if executed well.
• Risk Factors: Uncertainties around supply chain, innovation, and global economic conditions could create volatility and drive investor sentiment.
• Dividend Policy: The lack of dividend for 2025 may disappoint income-focused investors; future dividends are at Board’s discretion and dependent on profitability improvements.

Conclusion

Epiworld’s 2025 annual report reveals a company in transition: facing profitability challenges, but with a strengthened equity base and a successful Hong Kong IPO. Investors should closely monitor how management deploys newly raised capital, executes on supply chain and innovation strategies, and navigates macroeconomic risks. The share price may be sensitive to further earnings announcements, strategic actions, and global semiconductor market trends. The lack of dividend and weak profit may weigh on valuation unless future growth materializes.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult professional advisers before making investment decisions. The information is based on the company’s annual report and may be subject to change or interpretation.

View EPIWORLD Historical chart here